Autoimmune Disease Diagnostics Market and Forecast 2030
                     Autoimmune Disease Diagnostics Market
2024-2030
A comprehensive analysis of market size, growth projections, 
segmentation, regional trends, and key industry players in the global 
autoimmune diagnostics landscape
September 2025
Apelo Consulting
Market Overview & Size
Key Market Metrics
Market Growth Projection (2024-2030)
Market valued at USD 6,583 Million in 2024
Projected to reach USD 10,423 Million by 2030 
Robust 7.9% CAGR during the forecast period
Growth driven by increasing prevalence of
autoimmune conditions and technological
advancements
Page 2 Apelo Consulting
Understanding Autoimmune Diseases
80+ known types of autoimmune diseases Two Major Categories
worldwide
Abnormal immune response where the body's 
immune system attacks its own cells and tissues
Results in deterioration and destruction of healthy Organ-Specific Systemic
tissue Autoantibodies target a Autoantibodies attack 
specific organ multiple organ systems
Common examples: Hashimoto's thyroiditis (organ- Example: Hashimoto's Example: SLE affects tissues
thyroiditis attacks thyroid throughout body
specific) and Systemic Lupus Erythematosus gland
Rheumatoid arthritis, 
(systemic)
Type 1 diabetes, Multiple Ankylosing spondylitis
sclerosis
Page 3 Apelo Consulting
Market Drivers
Key Growth Factors
Global Autoimmune Disease Prevalence 
50+ million Americans currently affected by Trend
autoimmune disorders
Risingglobal prevalence across Asia-Pacific, Europe, 
and developing regions
Supportive government policies and increased 
healthcare funding
Growing demand for advanced diagnostic 
techniques with higher accuracy
Page 4 Apelo Consulting
Recent Market Developments
Key Innovations
APRIL 2025
Predicta Biosciences
Recent breakthroughs in autoimmune 
diagnostic technologies are transforming Launched its first molecular diagnostic product to optimize the 
prognosis of multiple myeloma, bringing advanced precision 
patient care and market landscape
oncology to autoimmune diagnostics
These innovations represent
significant advancements in FEBRUARY 2025
precision medicine for autoimmune Biocon Biologics
disease management Launched YESINTEK (ustekinumab-kfce), a biosimilar option to 
Stelara in the US market for Crohn's disease, ulcerative colitis, 
plaque psoriasis, and psoriatic arthritis
DECEMBER 2024
Quest Diagnostics
Introduced a revolutionary autoimmune disease diagnostic 
service using AI algorithms to analyze test results in real 
time, providing clinicians with instant feedback on patient 
status
Page 5 Apelo Consulting
Disease Segmentation
Localized Systemic Autoimmune
Autoimmune Diseases Diseases
Multiple Sclerosis Rheumatoid Arthritis 
Types of Autoimmune Diseases Highest market share in Over 50% of systemic market 
localized segment (2024) share (2024)
Autoimmune diseases are categorized into two 
Type 1 Diabetes Affects Systemic Lupus 
general groups based on their impact on the body: pancreatic islet cells Erythematosus Affects 
multiple body systems
Organ-specific: Autoantibodies target a Hashimoto's Thyroiditis
specific organ Targets the thyroid gland Systemic Sclerosis 
Causes skin and tissue 
Systemic: Autoantibodies attack Inflammatory Bowel hardening
multiple organ systems Disease
Ankylosing Spondylitis
Affects the digestive tract
Primarily affects the spine
Multiple Sclerosis Rheumatoid Arthritis
(Highest Share) Localized vs (>50%)
Systemic
Market Share
Page 6 ApeloConsulting
Test Types Analysis
Key Diagnostic Methods
Autoantibody Tests: Captured largest market 
share in 2024; used for diagnosing various Autoimmune Diagnostic Test Types Market 
autoimmune disorders Share (2024)
Antinuclear Antibody (ANA) Tests: Critical for 
diagnosing SLE, rheumatoid arthritis in 
primary care and specialty settings
Complete Blood Count (CBC): Essential 
for diagnosing SLE, Idiopathic 
Thrombocytopenic Purpura, and 
Multiple Sclerosis
Other Key Tests: ESR, CRP,
Urinalysis, and Comprehensive
Metabolic Panel Tests for
comprehensive diagnosis
Page 7 Apelo Consulting
Regional Market Analysis
Key Regional Insights
North America: Largest market share, driven Regional Market Share Distribution (2024)
by high prevalence rates and advanced 
healthcare infrastructure
Europe: Second-largest market, with 
multiple sclerosis prevalence at 83 per 
100,000 population
Asia-Pacific: Fastest-growing region, driven 
by large population, increasing disease 
prevalence, and healthcare investments
South America & Middle East/Africa: 
Emerging markets with significant 
growth potential
Page 8 Apelo Consulting
Key Market Players
Leading Diagnostics Companies
Abbott Laboratories
Market Positioning Matrix
Siemens Healthineers
Roche Diagnostics 
bioMerieux SA 
EUROIMMUN AG
Bio-Rad Laboratories 
Quest Diagnostics
Thermo Fischer Scientific Inc. 
Danaher Corporation
Page 9 Apelo Consulting
Market Forecast & Conclusion
Market Expected to Reach
USD 10,423 Million by 2030
Strong Growth Drivers Stakeholder Opportunities
Rising prevalence of autoimmune conditions worldwide Investment in AI-powered diagnostic tools
Technological innovation in diagnostic techniques Expansion into emerging markets in Asia-Pacific region
Supportive government policies and healthcare investments Strategic partnerships for comprehensive diagnostic solutions
Expanding awareness and early disease detection initiatives Development of point-of-care testing solutions
Market Growth Trend (2024-2030)
Page 10 Apelo Consulting